Alzheimer’s genetic test APOE gene
This test makes it possible to know if a person carries genetic variants associated with an increased risk of Alzheimer’s, which facilitates the adoption of personalized preventive measures, especially in people with a family history or additional risk factors.
Alzheimer’s genetic test APOE gene
180,00 €
What is the APOE gene genetic test?
The APOE gene test analyzes genetic variants associated with a higher or lower risk of developing late-onset Alzheimer’s disease. The APOE gene encodes a protein involved in lipid metabolism in the brain. There are three main variants of the gene: APOE ε2, ε3, and ε4, with the APOE ε4 variant being the one associated with the highest genetic risk.
The APOE ε4 variant is present in approximately 15% of the general population and in more than 50% of people with late-onset Alzheimer’s. However, carrying the variant does not mean that one will develop the disease, and not carrying it does not guarantee being free of risk. Therefore, this test should be understood as a screening tool, not a diagnostic one.
Who is this test indicated for?
People with a family history of Alzheimer’s disease
Adults over 40 interested in personalized prevention
People with cardiovascular, metabolic, or neurological risk factors
The results are delivered in a clear, understandable, and clinically useful report. This includes:
Interpretation of the APOE genetic profile
Follow-up and prevention recommendations
Receive the kit at home, collect the samples following the instructions, and we will come to pick it up.
The kit contains detailed instructions on how to collect the sample and request its pickup.
What should I keep in mind before taking the test?
No specific instructions need to be followed before taking the test.
Object of study
We evaluate the genetic predisposition to celiac disease
The celiac disease genetic predisposition test focuses on two specific genes: HLA-DQ2 and HLA-DQ8. Celiac disease is an autoimmune condition triggered by gluten ingestion in genetically susceptible individuals. The HLA-DQ2 and HLA-DQ8 genes encode histocompatibility proteins that play an important role in antigen presentation to immune system cells.
This test is used as a complementary diagnostic tool for people with symptoms of celiac disease. It can also be useful for first-degree relatives of patients with celiac disease to determine their genetic risk.
— Our Commitment
Rigor, quality, and technology
-
Commitment to your digestive health
At ADN Institut, we understand the importance of an accurate diagnosis for conditions like celiac disease. Therefore, we are committed to offering you reliable tools that help you understand your genetic predisposition. The DQ2/DQ8 test for celiac disease analyzes the genes associated with this disease, providing you with precise information that can make a difference in the prevention and management of your intestinal health.
-
Precision in genetic analysis
Our genetic test for celiac disease uses RT-PCR technology to identify the presence of the HLA-DQ2 and HLA-DQ8 haplotypes, which are directly related to the predisposition to developing celiac disease.
-
Personalized advice and professional support
The value of a genetic test lies in understanding its meaning. That's why our team of professionals offers you specialized advice to interpret the results and answer any questions you may have. We'll explain what having the DQ2 or DQ8 genes means and how this finding can impact your current and future health. We'll also guide you through the recommended steps, whether it's to rule out risks, perform additional testing, or define healthy eating habits. Our goal is to support you every step of the way, providing clear information and personalized solutions.
— Do you have any more questions?
Ask us your questions
Call us at +34 93 115 99 50, send us a message on WhatsApp, or fill out the form below: